{"id":590,"date":"2021-12-14T12:19:00","date_gmt":"2021-12-14T17:19:00","guid":{"rendered":"https:\/\/www.napra.ca\/?p=590"},"modified":"2022-08-17T12:21:38","modified_gmt":"2022-08-17T16:21:38","slug":"recommandations-provisoires-du-ccnam-quant-a-la-solution-ophtalmique-de-tartrate-de-brimonidine-a-une-concentration-inferieure-ou-egale-a-0025","status":"publish","type":"post","link":"https:\/\/www.napra.ca\/fr\/recommandations-provisoires-du-ccnam-quant-a-la-solution-ophtalmique-de-tartrate-de-brimonidine-a-une-concentration-inferieure-ou-egale-a-0025\/","title":{"rendered":"Recommandations provisoires du CCNAM quant \u00e0 la solution ophtalmique de tartrate de brimonidine \u00e0 une concentration inf\u00e9rieure ou \u00e9gale \u00e0 0,025 %"},"content":{"rendered":"\n<p>Le Comit\u00e9 consultatif national sur les annexes de m\u00e9dicaments (CCNAM) a tenu une rencontre le 6d\u00e9cembre 2021 et a propos\u00e9 les recommandations provisoires suivantes (disponibles qu&rsquo;en anglais) :<\/p>\n\n\n\n<ul class=\"wp-block-list\"><li>Brimonidine tartrate ophthalmic solution in concentrations up to and including 0.025%, used for the relief of redness of the eye due to minor eye irritations caused by environmental allergies, dryness and fatigue for adults of 18 years and older be granted Schedule III status, subject to the removal from the Prescription Drug List (PDL)<\/li><li>Brimonidine or its salts,&nbsp;<strong>except&nbsp;<\/strong>when sold as brimonidine tartrate ophthalmic solution in concentrations up to and including 0.025%, used for the relief of redness of the eye due to minor eye irritations caused by environmental allergies, dryness and fatigue for adults of 18 years and older will remain in Schedule I (as per the Prescription Drug List)<\/li><\/ul>\n\n\n\n<p>L\u2019ANORP doit recevoir toute objection \u00e0 ces recommandations provisoires\u00a0<strong>avant le 13 janvier 2022 en fin de journ\u00e9e<\/strong>. Veuillez envoyer toute question ou tout commentaire au secr\u00e9tariat du CCNAM en \u00e9crivant \u00e0\u00a0<a rel=\"noreferrer noopener\" href=\"mailto:ndsac@napra.ca\" target=\"_blank\">ndsac@napra.ca<\/a>.\u00a0<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Le Comit\u00e9 consultatif national sur les annexes de m\u00e9dicaments (CCNAM) a tenu une rencontre le 6d\u00e9cembre 2021 et a propos\u00e9 les recommandations provisoires suivantes (disponibles qu&rsquo;en anglais) : Brimonidine tartrate [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":443,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[18],"tags":[],"class_list":["post-590","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-mises-a-jour-des-anm"],"acf":[],"uagb_featured_image_src":{"full":["https:\/\/www.napra.ca\/wp-content\/uploads\/2022\/08\/news-NDS-generic.png",660,440,false],"thumbnail":["https:\/\/www.napra.ca\/wp-content\/uploads\/2022\/08\/news-NDS-generic-150x150.png",150,150,true],"medium":["https:\/\/www.napra.ca\/wp-content\/uploads\/2022\/08\/news-NDS-generic-300x200.png",300,200,true],"medium_large":["https:\/\/www.napra.ca\/wp-content\/uploads\/2022\/08\/news-NDS-generic.png",660,440,false],"large":["https:\/\/www.napra.ca\/wp-content\/uploads\/2022\/08\/news-NDS-generic.png",660,440,false],"1536x1536":["https:\/\/www.napra.ca\/wp-content\/uploads\/2022\/08\/news-NDS-generic.png",660,440,false],"2048x2048":["https:\/\/www.napra.ca\/wp-content\/uploads\/2022\/08\/news-NDS-generic.png",660,440,false],"gform-image-choice-sm":["https:\/\/www.napra.ca\/wp-content\/uploads\/2022\/08\/news-NDS-generic.png",300,200,false],"gform-image-choice-md":["https:\/\/www.napra.ca\/wp-content\/uploads\/2022\/08\/news-NDS-generic.png",400,267,false],"gform-image-choice-lg":["https:\/\/www.napra.ca\/wp-content\/uploads\/2022\/08\/news-NDS-generic.png",600,400,false]},"uagb_author_info":{"display_name":"Stephanie Smith","author_link":"https:\/\/www.napra.ca\/fr\/author\/stephflow\/"},"uagb_comment_info":0,"uagb_excerpt":"Le Comit\u00e9 consultatif national sur les annexes de m\u00e9dicaments (CCNAM) a tenu une rencontre le 6d\u00e9cembre 2021 et a propos\u00e9 les recommandations provisoires suivantes (disponibles qu&rsquo;en anglais) : Brimonidine tartrate [&hellip;]","_links":{"self":[{"href":"https:\/\/www.napra.ca\/fr\/wp-json\/wp\/v2\/posts\/590","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.napra.ca\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.napra.ca\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.napra.ca\/fr\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.napra.ca\/fr\/wp-json\/wp\/v2\/comments?post=590"}],"version-history":[{"count":0,"href":"https:\/\/www.napra.ca\/fr\/wp-json\/wp\/v2\/posts\/590\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.napra.ca\/fr\/wp-json\/wp\/v2\/media\/443"}],"wp:attachment":[{"href":"https:\/\/www.napra.ca\/fr\/wp-json\/wp\/v2\/media?parent=590"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.napra.ca\/fr\/wp-json\/wp\/v2\/categories?post=590"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.napra.ca\/fr\/wp-json\/wp\/v2\/tags?post=590"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}